CV Sciences, Inc. Announces Expansion with the Launch of CV Acute and New Immunity Product Line - Seite 3

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

CONTACT INFORMATION:
Investor Contact:
ICR
Scott Van Winkle
617-956-6736
[e-mail]

Media Contact:
ICR
Cory Ziskind
646-277-1232
[e-mail]

¹ Research code for Traditional Chinese Medicine Formula Shuang Huang Lian (V87 SHL)

² Rapid resolution liquid chromatography analysis and studies on the stability of SHL preparations. J Pharm Biomed Anal (2011)

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/51df40fe-a5f2-4795 ...